You searched for "ERS"

641 results found

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Take-home tinnitus care – Sound Relief App

Tinnitus is a condition that affects over 300 million people worldwide. Typically it manifests as a ringing or buzzing in the ears and while there is not yet a cure there are many ways for patients to manage their tinnitus....

Murder most foul, strange and unnatural

Hamlet, written by William Shakespeare at the very beginning of the 17th century has definite otological interest. The whole play is about young Prince Hamlet’s revenge for his father’s murder. The king is killed by Hamlet’s wicked uncle, who then...

History of ENT - Murder most foul, strange and unnatural

Hamlet written by William Shakespeare at the very beginning of the 17th century has definite otological interest. The whole play is about young Prince Hamlet’s revenge for his father’s murder. The king is killed by Hamlet’s wicked uncle, who then...

Consultation on cochlear implantation guidelines

A taskforce of 52 hearing experts has released Living Guidelines for hearing care.

Deaf identity is not cookie cutter shaped: a CI user in a hearing world

Sam Burgess tells us what deaf identity means to her as a service manager in a busy healthcare library, with a cochlear Implant. To begin with, I have been deaf since birth due to congenital rubella. I have not known...

Re-establishing ENT services in Liberia after three decades

Liberia is a country located on the West African coast bordered by Guinea, Sierra Leone and the Ivory Coast. Founded in 1821, it is Africa’s oldest modern republic and was established on land acquired for freed US slaves by the...

VACANCY: Consultant Otolaryngologist, Wellington, New Zealand

Location: Wellington Regional Hospital, Kenepuru Hospital and Hutt Hospital

FDA Approved Lenire Expands Number of US Clinics

Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

Face shield modification in ENT during COVID-19 pandemic

The COVID pandemic has caused a huge disruption to our lives, not least at work where safety restrictions and the widespread implementation of PPE have led to some challenges to carrying out routine ENT work. In this article, the authors...

Cambodian Otology Fellowship report

Further to a Humanitarian News article published in the November/December 2014 issue of ENT and Audiology News (see article here), this is a report of Charlie Huins’ six-month experience as the first ENT Fellow at the Children’s Surgical Centre (CSC),...